Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (23)

« Back to Publications

A Langendorff-heart discovery pipeline demonstrates cardiomyocyte targeting by extracellular vesicles functionalized with beta-blockers using click-chemistry.

Park KC. et al, (2025), J Mol Cell Cardiol, 204, 89 - 100

Disrupted propionate metabolism evokes transcriptional changes in the heart by increasing histone acetylation and propionylation.

Park KC. et al, (2023), Nat Cardiovasc Res, 2, 1221 - 1245

Integrated Proteomics Unveils Nuclear PDE3A2 as a Regulator of Cardiac Myocyte Hypertrophy.

Subramaniam G. et al, (2023), Circ Res, 132, 828 - 848

Alkaline nucleoplasm facilitates contractile gene expression in the mammalian heart.

Hulikova A. et al, (2022), Basic Res Cardiol, 117

Stored blood has compromised oxygen unloading kinetics that can be normalized with rejuvenation and predicted from corpuscular side-scatter.

Donovan K. et al, (2022), Haematologica, 107, 298 - 302

Alkaline nucleoplasm facilitates contractile gene expressionin the mammalian heart

Hulikova A. et al, (2022), ACTA PHYSIOLOGICA, 236, 48 - 49

Elevated propionate signalling drives Pde9a overexpression and contractile dysfunction through increased histone acetylation and propionylation

Park KC. et al, (2022), CARDIOVASCULAR RESEARCH, 118

Elevated propionate/propionyl-CoA signalling drives Pde9a overexpression and contractile dysfunction through increased histone acetylation and propionylation

Park KC. et al, (2022), JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 173, S50 - S50

Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart.

Chung YJ. et al, (2021), Cardiovasc Res, 117, 2794 - 2806

SGLT2 inhibitors and the cardiac Na+/H+ exchanger-1: the plot thickens.

Chung YJ. et al, (2021), Cardiovasc Res, 117, 2702 - 2704

Subtle Role for Adenylate Kinase 1 in Maintaining Normal Basal Contractile Function and Metabolism in the Murine Heart.

Zervou S. et al, (2021), Front Physiol, 12

Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.

Park KC. et al, (2020), Br J Haematol, 190, e229 - e232

Cardiac Complications of Propionic and Other Inherited Organic Acidemias.

Park KC. et al, (2020), Front Cardiovasc Med, 7

Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na/H exchanger-1 or lower intracellular Na in rat and mouse heart

Chung YJYJ. et al, (2020), EUROPEAN JOURNAL OF HEART FAILURE, 22, 283 - 283

Iron-deficiency anemia reduces cardiac contraction by downregulating RyR2 channels and suppressing SERCA pump activity.

Chung YJ. et al, (2019), JCI Insight, 4

Load More